Collplant Biotechnologies Stock Probability of Future Stock Price Finishing Over 13.30
| CLGN Stock | USD 4.25 0.01 0.23% |
Collplant |
Collplant Biotechnologies Target Price Odds to finish over 13.30
The tendency of Collplant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 13.30 or more in 90 days |
| 4.25 | 90 days | 13.30 | close to zero percent |
Based on a normal probability distribution, the odds of Collplant Biotechnologies to move over $ 13.30 or more in 90 days from now is close to zero percent (This Collplant Biotechnologies probability density function shows the probability of Collplant Stock to fall within a particular range of prices over 90 days) . Probability of Collplant Biotechnologies price to stay between its current price of $ 4.25 and $ 13.30 at the end of the 90-day period is about 69.85 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.22 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Collplant Biotechnologies will likely underperform. Additionally Collplant Biotechnologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Collplant Biotechnologies Price Density |
| Price |
Predictive Modules for Collplant Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Collplant Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Collplant Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Collplant Biotechnologies is not an exception. The market had few large corrections towards the Collplant Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Collplant Biotechnologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Collplant Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.38 | |
β | Beta against Dow Jones | 1.22 | |
σ | Overall volatility | 0.50 | |
Ir | Information ratio | -0.11 |
Collplant Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Collplant Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Collplant Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Collplant Biotechnologies generated a negative expected return over the last 90 days | |
| Collplant Biotechnologies has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 10.96 M. Net Loss for the year was (7.02 M) with profit before overhead, payroll, taxes, and interest of 13.64 M. | |
| Collplant Biotechnologies currently holds about 36.29 M in cash with (2.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.27. | |
| Collplant Biotechnologies has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: What To Expect From CollPlant Biotechnologies Ltd Q3 2024 Earnings |
Collplant Biotechnologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Collplant Stock often depends not only on the future outlook of the current and potential Collplant Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Collplant Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.4 M | |
| Cash And Short Term Investments | 26.7 M |
Collplant Biotechnologies Technical Analysis
Collplant Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Collplant Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Collplant Biotechnologies. In general, you should focus on analyzing Collplant Stock price patterns and their correlations with different microeconomic environments and drivers.
Collplant Biotechnologies Predictive Forecast Models
Collplant Biotechnologies' time-series forecasting models is one of many Collplant Biotechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Collplant Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Collplant Biotechnologies
Checking the ongoing alerts about Collplant Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Collplant Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Collplant Biotechnologies generated a negative expected return over the last 90 days | |
| Collplant Biotechnologies has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 10.96 M. Net Loss for the year was (7.02 M) with profit before overhead, payroll, taxes, and interest of 13.64 M. | |
| Collplant Biotechnologies currently holds about 36.29 M in cash with (2.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.27. | |
| Collplant Biotechnologies has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: What To Expect From CollPlant Biotechnologies Ltd Q3 2024 Earnings |
Check out Collplant Biotechnologies Backtesting, Collplant Biotechnologies Valuation, Collplant Biotechnologies Correlation, Collplant Biotechnologies Hype Analysis, Collplant Biotechnologies Volatility, Collplant Biotechnologies History as well as Collplant Biotechnologies Performance. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share 0.06 | Quarterly Revenue Growth (0.98) | Return On Assets (0.34) | Return On Equity (0.62) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.